Macrolide Use in the Treatment of Critically Ill Patients with Pneumonia: Incidence, Correlates, Timing and Outcomes
BACKGROUND: Macrolide antibiotics are commonly used to treat pneumonia despite increasing antimicrobial resistance. Evidence suggests that macrolides may also decrease mortality in severe sepsis via immunomodulatory properties.
Saved in:
Main Authors: | Wendy I Sligl, Holly Hoang, Dean T Eurich, Atul Malhotra, Thomas J Marrie, Sumit R Majumdar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2013/652512 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compassionate Use of Omadacycline in a Down Syndrome Pre-Schooler With Critically Ill Atypical Pneumonia Caused by Macrolide-Resistant Mycoplasma Pneumoniae
by: Wu D, et al.
Published: (2025-01-01) -
Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments
by: T. J. Marrie, et al.
Published: (2017-01-01) -
Correlation of cytokine storm with ocular fundus abnormalities in critically ill patients with severe viral pneumonia
by: Yun Yu, et al.
Published: (2025-02-01) -
Future Uses of Newer Macrolides
by: John Segreti
Published: (1993-01-01) -
Macrolides in Chronic Inflammatory Skin Disorders
by: Abdullateef A. Alzolibani, et al.
Published: (2012-01-01)